Fluid Balance During Surgery for Ovarian Cancer

• Conditions: Ovarian Neoplasm; Fluid Therapy

• Registration Number: NCT03006939
• Lead Sponsor: University Hospital, Bonn

Brief Summary

Extensive tumour debulking challenges both surgeon and anaesthesiologist but promotes survival in late-stage ovarian cancer patients. Little is known about the intraoperative fluid balance and its impact on morbidity and mortality.

Detailed Description

Not available

Study Timeline

• Status Verified: 2016-12
• Study Start: 2016-12
• Study First Submitted: 2016-12-14
• Study First Submitted QC: 2016-12-29
• Last Update Submitted: 2016-12-29
• Study First Posted: 2016-12-30
• Last Update Posted: 2016-12-30
• Primary Completion: 2019-12
• Study Completion: 2022-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

• patients scheduled for cytoreductive surgery in ovarian cancer

Exclusion Criteria

• Age < 18 years
• unability to give consent

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
fluid balance	at the end of surgery	intraoperative fluid balance is determined by the difference between fluid intake and outtake

Secondary Outcome Measures

Name	Time	Method
mechanical ventilation	at the timepoint of extubation	Duration of mechanical ventilation, starting from endotracheal intubation until extubation
mortality	5 years	long-term mortality after surgery

Trial Locations

Locations (1)

Dept. of Anaesthesiology and Intensive Care Medicine, University of Bonn; 🇩🇪 Bonn, Germany